BACKGROUND: Problematic hypoglycaemia is a significant problem among @entity1 with insulin-treated type 1 and 2 @entity6 , which adversely affects quality of life and leads to high societal costs. Blood @entity413 awareness training (BGAT) is a psycho-educational group intervention that has shown to be effective but difficult to implement in clinical practice, due to its demanding nature. The aim of this study is to evaluate the cost-effectiveness of the HypoAware intervention that has its roots in BGAT and helps @entity1 to effectively recognize, treat and prevent hypoglycaemia, while also focussing on the psychosocial consequences of living with the constant risk of hypoglycaemia, both for @entity1 and their significant others. METHODS/DESIGN: An economic evaluation will be conducted alongside a cluster-randomised controlled trial in eight hospitals in the Netherlands. We aim to include 154 @entity1 who will either receive HypoAware or care as usual. HypoAware consists of three group sessions and is combined with two online modules. The primary clinical outcome is severe hypoglycaemia. Secondary outcomes include mild hypoglycaemia, hypoglycaemia awareness, fear of hypoglycaemia, @entity6 , @entity148 and @entity308 , health-related quality of life, @entity6 -specific self-efficacy and HbA1c. Utilities will be measured using the EQ-5D-5  L questionnaire. Costs will be measured from a societal perspective and include health care utilization, medication and lost productivity costs. Measurements will be performed at baseline, 2, 4, and 6  months to compare both groups, and an additional 12  months for the intervention group only. Process outcomes will be gathered after every group meeting via telephone/email contact with health care professionals and via the online environment. DISCUSSION: HypoAware is expected to significantly reduce episodes of severe hypoglycaemia, with subsequent beneficial effects on psychosocial outcomes and health care costs. When proven cost-effective, HypoAware will be incorporated in the clinical guidelines of Dutch @entity6 care. TRIAL REGISTRATION: Dutch Trial Register NTR4538.

HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 XXXX and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial.

@entity1 :: ('9606', 'Species') :: ['participants', 'patients', 'people'] @entity308 :: ('MESH:D003866', 'Disease') :: ['depression'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes distress', 'diabetes', 'diabetes mellitus'] @entity148 :: ('MESH:D001008', 'Disease') :: ['anxiety'] @entity413 :: ('MESH:D005947', 'Chemical') :: ['glucose']
@entity6 :: (MESH:D003920,Disease) :: ['diabetes']
